Searchable abstracts of presentations at key conferences in endocrinology

ea0041s15.1 | In the rhythm of EYES: Let's dance! | ECE2016

The Microbiome Waltz – cross-regulation of rhythmic oscillations at the host-microbiota interface

Thaiss Christoph

All domains of life feature diverse molecular clock machineries that synchronize physiological processes to diurnal environmental fluctuations. However, no mechanisms are known to cross-regulate prokaryotic and eukaryotic circadian rhythms in multi-kingdom ecosystems. We discovered that the intestinal microbiota, in both mice and humans, exhibits diurnal oscillations, leading to time-specific compositional and functional profiles over the course of a day. The active phase of t...

ea0041oc12.4 | Obesity | ECE2016

GLP-1 directed delivery of dexamethasone ameliorates hypothalamic inflammation and reverses diet-induced obesity

Quarta Carmelo , Clemmensen Christoffer , Yang Bin , Zhu Zhimeng , Muller Timo D , DiMarchi Richard D , Finan Brian , Tschop Matthias H

Abstract: Inflammation plays a contributing role in the pathogenesis of several metabolic disorders, including type 2 diabetes and obesity. Intriguingly, obesogenic diets induce markers of hypothalamic inflammation and neuronal injury in both rodents and humans, suggesting that targeting inflammatory pathways in the hypothalamus might represent a novel strategy to control energy metabolism. Unfortunately, the majority of steroid-based anti-inflammatory drugs are fraught with a...

ea0041gp195 | Thyroid - Basic | ECE2016

Accumulation of PD-1-positve and PD-L1-positve T and B lymphocytes in patients with Graves’ disease

Pyzik Aleksandra , Grywalska Ewelina , Matyjaszek-Matuszek Beata , Kiszczak-Bochynska Ewa , Rolinski Jacek

Introduction: Programmed death-1 (PD-1) is one of the most important inhibitory co-receptors. Studies show that the PD-1/PD-L1 pathway regulates the induction and maintenance of peripheral tolerance and protects tissues from autoimmune attack in physiological conditions. Several studies have shown association of PD-1/PD-L1 pathway with several autoimmune diseases although, to date, no such studies have been performed for Graves’ disease (GD).Aims: T...

ea0041gp218 | Thyroid - Translational & Clinical (1) | ECE2016

Relationship between immunoexpression of IL17A, CD68 positivity and lymphocyte infiltration degree in Hashimoto’s thyroiditis patients

Konrade Ilze , Zake Tatjana , Skuja Sandra , Kalere Ieva , Groma Valerie

Introduction: Th17 cells and their hallmark cytokine IL-17A were reported to be involved in the development of autoimmune orchitis and encephalomyelitis by impairing the integrity of the blood–testis and blood–brain barrier integrity and by inducing local inflammation. However, the role of IL17A in autoimmune thyroid disease is still debatable.The aim of our study was to estimate immunoexpression of IL-17A in the thyroid tissue of patients with...

ea0041ep777 | Obesity | ECE2016

A prostate cancer risk associated polymorphism regulates androgen mediated regulation of a novel long noncoding RNA, IRX4lncRNA

Panchadsaram Janaththani , Tevz Gregor , Stylianou Nataly , Hollier Brett , Nelson Colleen , Williams Elizabeth , Clements Judith , Batra Jyotsna

Prostate cancer (PCa) is the second most common cause of cancer death in developed countries. Our RNAseq analysis identified a novel long non-coding RNA, IRX4lncRNA at chromosome 5p15. The expression of IRX4lncRNA was much higher in prostate tumor samples (n=50) compared to their matched controls. Moreover, knockdown of lncRNA reduced the cell proliferation of LNCaP cells and this lncRNA was down-regulated in the cells undergoing Epithelial ...

ea0041ep891 | Pituitary - Clinical | ECE2016

Non-alcoholic fatty liver disease in patients with biochemically cured Cushing’s disease and non-functioning pituitary adenomas: role of adrenal insufficiency and growth hormone deficiency

Auer Matthias K , Stieg Mareike R , Stalla Gunter K

Objective: Nonalcoholic fatty liver disease (NAFLD) is a hallmark of the metabolic syndrome and has been shown to be an independent predictor of cardiovascular mortality. Although glucocorticoids and growth hormone are known to be implicated in its pathophysiology, it has only rarely been investigated in the context of patients with pituitary insufficiency or former cortisol excess.Design: Case-control study, including patients with biochemically control...

ea0059p041 | Bone and calcium | SFEBES2018

Management of osteogenesis imperfecta in adulthood – a single centre experience

Dar Shujah , Khalily Naveed , Khan Shakib , Kamwa Vicky , Cole Trevor , Ayuk John , Gittoes Neil , Hassan-Smith Zaki

Introduction: Osteogenesis imperfecta (OI) is a genetic, heterogeneous, connective tissue disorder most commonly caused by mutations in type I collagen genes. A hallmark of disease is frequent fractures that are precipitated by minimal trauma. There are limited data on the impact of OI on non-skeletal outcomes across the lifecourse. We present cross-sectional data of one of the largest single centre patient cohorts of OI in adulthood (n=186).The aim of this study was ...

ea0059cc1 | Featured Clinical Cases | SFEBES2018

Pitfalls in the diagnosis of an infant with 46,XX DSD with Congenital Adrenal Hyperplasia due to Cytochrome P450 Oxidoreductase deficiency - the value of simultaneous genetic analysis to the diagnosis in DSD

Idkowiak Jan , Mohamed Zainaba , Allen Stephanie , Chandran Harish , McCarthy Liam , Kirk Jeremy , Cole Trevor , Krone Nils

Background: Congenital adrenal hyperplasia (CAH) is the underlying diagnosis in most newborns presenting with 46,XX disorders of sex development (DSD). Cytochrome P450 oxidoreductase deficiency (PORD) is a rare form of CAH caused by inactivating mutations in the POR gene. The hallmark feature of PORD is combined sex-steroid and glucocorticoid deficiency due to impairment of CYP17A1 and CYP21A2. Skeletal malformations resembling the Antley-Bixler Syndrome phenotype are common i...

ea0038fp12 | (1) | SFEBES2015

Characterising the functional significance of the first reported mutations in the pituitary tumor-transforming gene binding factor

Imruetaicharoenchoke Waraporn , Watkins Rachel , Modasia Bhavika , Poole Vikki , Fletcher Alice , Thompson Rebecca , Boelaert Kristien , Smith Vicki , Read Martin , McCabe Christopher

Pituitary tumor-transforming gene binding factor (PBF) is a ubiquitous glycoprotein which is over-expressed in thyroid, breast and other endocrine cancers, and modulates cellular invasion, radioiodine uptake and thyroid hormone efflux. Papillary thyroid cancer patients with high PBF expression show decreased disease-specific survival compared to those with lower expression. PBF expression has recently been correlated with breast cancer metastasis and colon cancer extra-mural v...

ea0038p240 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2015

Effects of androgen on the adipokinome and metabolic genes in white and brown adipose tissue

Lerner Avi , Kewada Drashti , Okolo Anthony , Hardy Kate , Franks Stephan

Polycystic ovary syndrome (PCOS) is a common endocrinopathy that is associated with an adverse metabolic profile including insulin resistance and dyslipidaemia. Hyperandrogenism is the hallmark of PCOS and obesity increases androgen synthesis, partly due to accompanying hyperinsulinemia but also as a result of adipokines affecting ovarian steroidogenesis (Comim et al., 2013, PLoS ONE 8(11). Adipokines are factors secreted by adipose tissue and while a clear link betwe...